Ciobârcă, D.; Cătoi, A.F.; Gavrilaș, L.; Banc, R.; Miere, D.; Filip, L.
Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease. Pharmaceuticals 2025, 18, 279.
https://doi.org/10.3390/ph18020279
AMA Style
Ciobârcă D, Cătoi AF, Gavrilaș L, Banc R, Miere D, Filip L.
Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease. Pharmaceuticals. 2025; 18(2):279.
https://doi.org/10.3390/ph18020279
Chicago/Turabian Style
Ciobârcă, Daniela, Adriana Florinela Cătoi, Laura Gavrilaș, Roxana Banc, Doina Miere, and Lorena Filip.
2025. "Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease" Pharmaceuticals 18, no. 2: 279.
https://doi.org/10.3390/ph18020279
APA Style
Ciobârcă, D., Cătoi, A. F., Gavrilaș, L., Banc, R., Miere, D., & Filip, L.
(2025). Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease. Pharmaceuticals, 18(2), 279.
https://doi.org/10.3390/ph18020279